MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 118 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,653,000 | -60.9% | 1,333,311 | -3.0% | 0.00% | -50.0% |
| Q1 2017 | $4,233,000 | +11.6% | 1,374,195 | +47.8% | 0.00% | 0.0% |
| Q4 2016 | $3,794,000 | -9.8% | 929,954 | +34.1% | 0.00% | 0.0% |
| Q3 2016 | $4,207,000 | +48.0% | 693,611 | +31.5% | 0.00% | +100.0% |
| Q2 2016 | $2,842,000 | -35.6% | 527,326 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,414,000 | -13.2% | 527,326 | -18.1% | 0.00% | -33.3% |
| Q4 2015 | $5,087,000 | +40.6% | 643,876 | +51.5% | 0.00% | +50.0% |
| Q3 2015 | $3,618,000 | – | 425,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
| KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
| Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
| GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
| Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
| Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
| STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
| Birchview Capital, LP | 44,000 | $136,000 | 0.08% |